Answers are grounded in this paper and cite their sources.
Shows Poria cocos extract alleviates tPA-induced hemorrhagic transformation after ischemic stroke by regulating microglial polarization, highlighting a potential strategy to reduce thrombolysis...
Delayed thrombolytic therapy with tissue plasminogen activator (tPA), the only FDA-approved drug for ischemic stroke, can cause catastrophic hemorrhagic transformation (HT) after ischemic stroke. However, it remains largely unknown how microglial polarization dynamically changes in HT.
No takes yet. Share an insight, caveat, or question.
Li et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: